Germline genetic regulation of the colorectal tumor immune microenvironment

被引:1
|
作者
Schmit, Stephanie L. [1 ,2 ]
Tsai, Ya-Yu [1 ]
Bonner, Joseph D. [3 ]
Sanz-Pamplona, Rebeca [4 ,5 ,6 ]
Joshi, Amit D. [7 ,8 ]
Ugai, Tomotaka [8 ,9 ]
Lindsey, Sidney S. [3 ]
Melas, Marilena [12 ]
McDonnell, Kevin J. [3 ]
Idos, Gregory E. [3 ]
Walker, Christopher P. [3 ]
Qu, Chenxu [12 ]
Kast, W. Martin [12 ]
Da Silva, Diane M. [12 ]
Glickman, Jonathan N. [11 ]
Chan, Andrew T. [7 ,10 ,13 ,14 ,15 ]
Giannakis, Marios [14 ,16 ]
Nowak, Jonathan A. [9 ,16 ]
Rennert, Hedy S. [17 ,18 ]
Robins, Harlan S. [19 ]
Ogino, Shuji [8 ,9 ,14 ,20 ]
Greenson, Joel K. [21 ]
Moreno, Victor [4 ,5 ,6 ,22 ]
Rennert, Gad [17 ,18 ]
Gruber, Stephen B. [3 ]
机构
[1] Cleveland Clin, Genom Med Inst, Cleveland Hts, OH 44195 USA
[2] Case Comprehens Canc Ctr, Populat & Canc Prevent Program, Cleveland, OH 44106 USA
[3] City Hope Natl Med Ctr, Ctr Precis Med, Duarte, CA 91010 USA
[4] Catalan Inst Oncol ICO, Lhospitalet De Llobregat, Barcelona, Spain
[5] Bellvitge Biomed Res Inst IDIBELL, Oncobell Program, Lhospitalet De Llobregat, Barcelona, Spain
[6] CIBERESP, Consortium Biomed Res Epidemiol & Publ Hlth, Barcelona, Spain
[7] Harvard Med Sch, Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA USA
[8] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[9] Brigham & Womens Hosp, Dept Pathol, Program MPE Mol Pathol Epidemiol, Boston, MA USA
[10] Harvard Med Sch, Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA USA
[11] Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA
[12] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA
[13] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA USA
[14] Broad Inst MIT & Harvard, Cambridge, MA USA
[15] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA
[16] Dana Farber Canc Inst, Boston, MA USA
[17] Technion, B Rappaport Fac Med, Haifa, Israel
[18] Assoc Promot Res Precis Med APRPM, Haifa, Israel
[19] Adapt Biotechnol Corp, Seattle, WA USA
[20] Tokyo Med & Dent Univ, Inst Sci Tokyo, Tokyo, Japan
[21] Univ Michigan, Dept Pathol, Ann Arbor, MI USA
[22] Univ Barcelona, Fac Med, Dept Clin Sci, Barcelona, Spain
来源
BMC GENOMICS | 2024年 / 25卷 / 01期
关键词
Genetic polymorphisms; T cell responses; Colorectal Cancer; GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; SUSCEPTIBILITY LOCI; INFILTRATING LYMPHOCYTES; CANCER; RISK; PEMBROLIZUMAB; METAANALYSIS; PROFILES; VARIANT;
D O I
10.1186/s12864-024-10295-1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
ObjectiveTo evaluate the contribution of germline genetics to regulating the briskness and diversity of T cell responses in CRC, we conducted a genome-wide association study to examine the associations between germline genetic variation and quantitative measures of T cell landscapes in 2,876 colorectal tumors from participants in the Molecular Epidemiology of Colorectal Cancer Study (MECC).MethodsGermline DNA samples were genotyped and imputed using genome-wide arrays. Tumor DNA samples were extracted from paraffin blocks, and T cell receptor clonality and abundance were quantified by immunoSEQ (Adaptive Biotechnologies, Seattle, WA). Tumor infiltrating lymphocytes per high powered field (TILs/hpf) were scored by a gastrointestinal pathologist. Regression models were used to evaluate the associations between each variant and the three T-cell features, adjusting for sex, age, genotyping platform, and global ancestry. Three independent datasets were used for replication.ResultsWe identified a SNP (rs4918567) near RBM20 associated with clonality at a genome-wide significant threshold of 5 x 10- 8, with a consistent direction of association in both discovery and replication datasets. Expression quantitative trait (eQTL) analyses and in silico functional annotation for these loci provided insights into potential functional roles, including a statistically significant eQTL between the T allele at rs4918567 and higher expression of ADRA2A (P = 0.012) in healthy colon mucosa.ConclusionsOur study suggests that germline genetic variation is associated with the quantity and diversity of adaptive immune responses in CRC. Further studies are warranted to replicate these findings in additional samples and to investigate functional genomic mechanisms.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Nucleotide metabolism in the regulation of tumor microenvironment and immune cell function
    Madsen, Helena B.
    Peeters, Marlies J. W.
    Straten, Per Thor
    Desler, Claus
    CURRENT OPINION IN BIOTECHNOLOGY, 2023, 84
  • [32] Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment
    Drakes, Maureen L.
    Stiff, Patrick J.
    CANCERS, 2018, 10 (09)
  • [33] Immune regulation in the tumor microenvironment and its relevance in cancer therapy
    Zou, Weiping
    CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (01) : 1 - 2
  • [34] Recombinant Poxvirus and the Tumor Microenvironment: Oncolysis, Immune Regulation and Immunization
    Sharp, DanielW.
    Lattime, Edmund C.
    BIOMEDICINES, 2016, 4 (03)
  • [35] Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment
    Harjunpaa, Heidi
    Asens, Marc Llort
    Guenther, Carla
    Fagerholm, Susanna C.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [36] The tumor immune microenvironment of germline BRCA1/2 and sporadic prostate cancer
    Trigos, Anna S.
    Pasam, Anupama
    Banks, Patricia Diana
    Wallace, Roslyn
    Keam, Simon P.
    Thorne, Heather
    Mitchell, Catherine
    Clouston, David
    Murphy, Declan G.
    Lawrentschuk, Nathan
    Bolton, Damien M.
    Moon, Daniel
    Castro, Elena
    Olmos, David
    Darcy, Phillip K.
    Haupt, Ygal
    Williams, Scott
    Goode, David L.
    Neeson, Paul J.
    Sandhu, Shahneen Kaur
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [37] Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response
    Pagadala, Meghana
    Sears, Timothy J.
    Wu, Victoria H.
    Perez-Guijarro, Eva
    Kim, Hyo
    Castro, Andrea
    Talwar, James V.
    Gonzalez-Colin, Cristian
    Cao, Steven
    Schmiedel, Benjamin J.
    Goudarzi, Shervin
    Kirani, Divya
    Au, Jessica
    Zhang, Tongwu
    Landi, Teresa
    Salem, Rany M.
    Morris, Gerald P.
    Harismendy, Olivier
    Patel, Sandip Pravin
    Alexandrov, Ludmil B.
    Mesirov, Jill P.
    Zanetti, Maurizio
    Day, Chi-Ping
    Fan, Chun Chieh
    Thompson, Wesley K.
    Merlino, Glenn
    Gutkind, J. Silvio
    Vijayanand, Pandurangan
    Carter, Hannah
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [38] Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response
    Meghana Pagadala
    Timothy J. Sears
    Victoria H. Wu
    Eva Pérez-Guijarro
    Hyo Kim
    Andrea Castro
    James V. Talwar
    Cristian Gonzalez-Colin
    Steven Cao
    Benjamin J. Schmiedel
    Shervin Goudarzi
    Divya Kirani
    Jessica Au
    Tongwu Zhang
    Teresa Landi
    Rany M. Salem
    Gerald P. Morris
    Olivier Harismendy
    Sandip Pravin Patel
    Ludmil B. Alexandrov
    Jill P. Mesirov
    Maurizio Zanetti
    Chi-Ping Day
    Chun Chieh Fan
    Wesley K. Thompson
    Glenn Merlino
    J. Silvio Gutkind
    Pandurangan Vijayanand
    Hannah Carter
    Nature Communications, 14
  • [39] Role of amino acid metabolism in tumor immune microenvironment of colorectal cancer
    Zhu, Minjing
    Hu, Yanyan
    Gu, Yangjia
    Lin, Xuedan
    Jiang, Xiang
    Gong, Chaoju
    Fang, Zejun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2025, 15 (01): : 233 - 247
  • [40] Characterization of the immune microenvironment of synchronous primary tumor and liver colorectal metastases
    Van Den Eynde, Marc
    Mlecnik, Bernhard
    Machiels, Jean-Pascal H.
    Debetancourt, Daphne
    Bindea, Gabriela
    Jouret-Mourin, Anne
    Sempoux, Christine
    Carrasco, Javier
    Gigot, Jean Francois
    Hubert, Catherine
    Humblet, Yves
    Haicheur, Nacilla
    Marliot, Florence
    Pages, Franck
    Galon, Jerome
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)